University of California Berkeley-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:University of California Berkeley - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013338
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
University of California Berkeley (UC Berkeley), a subsidiary of University of California is an educational university that offers educational programs and research services. The university’s academic programs comprise law and economics program, legal studies; lesbian, gay, bisexual, and transgender studies, letters and science, liberal arts, linguistics, logic and the methodology of sciencebiophysics, biostatistics, buddhist studies, cognitive science, development practice, integrative biology, interdisciplinary studies, Jewish studies program, mathematics, and others. It carries out research in partnership with academic departments, institutes and centers, museums, and field stations. The university provides educational services through its colleges and schools. UC Berkeley is headquartered in Berkeley, California, the US.

University of California Berkeley – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
University of California Berkeley, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
University of California Berkeley, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
University of California Berkeley, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
University of California Berkeley, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
University of California Berkeley, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
University of California Berkeley, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Novartis Enters into Agreement with University of California 10
University of California, Berkeley Enters into Agreement with Aduro Biotech 11
University Of California Announces Co-Development Agreement With Harvard University 12
Licensing Agreements 13
Excision BioTherapeutics Enters into Licensing Agreement with University of California Berkeley 13
Aduro BioTech Enters into Licensing Agreement with UCB 14
Aduro BioTech Amends Licensing Agreement with University of California, Berkeley 15
Aduro BioTech Enters into Licensing Agreement with University of California, Berkeley 16
Avalanche Biotechnologies Enters Into Licensing Agreement With University of California, Berkeley 17
University of California Berkeley – Key Competitors 18
University of California Berkeley – Key Employees 19
University of California Berkeley – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Government and Public Interest 21
Nov 06, 2017: Scientists discover potential treatment to stop glaucoma in its tracks 21
Jul 19, 2017: UC Berkeley: Defense department pours $65 million into making CRISPR safer 23
Jul 19, 2017: DARPA: Building the Safe Genes Toolkit 25
Jul 12, 2017: Anti-CRISPR proteins decrease off-target side effects of CRISPR-Cas9 28
Jan 13, 2017: Scientists reprogram embryonic stem cells to expand their potential cell fates 30
Sep 22, 2016: Kenneth Rainin Foundation Awards Over $3 Million to High-Risk, High Reward Inflammatory Bowel Disease Research Projects 32
Jul 26, 2016: With Rise of Leukemia in Children, $6 Million Grant Funds Search for Causes 34
Mar 02, 2016: PET scans reveal key details of Alzheimer’s protein growth in aging brains 36
Jan 25, 2016: Crouching Protein, Hidden Enzyme : The Scripps Research Institute 38
Appendix 40
Methodology 40
About GlobalData 40
Contact Us 40
Disclaimer 40

List of Tables
University of California Berkeley, Pharmaceuticals & Healthcare, Key Facts 2
University of California Berkeley, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
University of California Berkeley, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
University of California Berkeley, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
University of California Berkeley, Deals By Therapy Area, 2011 to YTD 2017 8
University of California Berkeley, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Novartis Enters into Agreement with University of California 10
University of California, Berkeley Enters into Agreement with Aduro Biotech 11
University Of California Announces Co-Development Agreement With Harvard University 12
Excision BioTherapeutics Enters into Licensing Agreement with University of California Berkeley 13
Aduro BioTech Enters into Licensing Agreement with UCB 14
Aduro BioTech Amends Licensing Agreement with University of California, Berkeley 15
Aduro BioTech Enters into Licensing Agreement with University of California, Berkeley 16
Avalanche Biotechnologies Enters Into Licensing Agreement With University of California, Berkeley 17
University of California Berkeley, Key Competitors 18
University of California Berkeley, Key Employees 19
University of California Berkeley, Subsidiaries 20

★海外企業調査レポート[University of California Berkeley-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • EryDel SPA:製薬・医療:M&Aディール及び事業提携情報
    Summary EryDel SPA (EryDel), a subsidiary of Genextra Spa is a drug delivery company that develops drugs and diagnostics delivered through human red blood cells using a proprietary medical device technology. The company’s products include red cell loaders, and disposable kits for drug encapsulation …
  • Aslan Pharmaceuticals Pte Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Aslan Pharmaceuticals Pte Ltd (Aslan), a subsidiary of Aslan Pharmaceuticals Ltd is a biotechnology company that offers immuno-oncology agents and targeted therapies. The company’s pipeline products comprise varlitinib, ASLAN002, ASLAN003 and ASLAN004. Its ASLAN002 is a small molecule inhibi …
  • America Movil SAB DE CV (AMXL):企業の財務・戦略的SWOT分析
    America Movil SAB DE CV (AMXL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Ortho-Clinical Diagnostics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Ortho-Clinical Diagnostics Inc (OCD), a subsidiary of The Carlyle Group L.P., is a provider of in vitro diagnostic products and services. The company designs, develops, manufactures and distributes in-vitro diagnostic products. It serves clinical laboratories by providing comprehensive solut …
  • Clydesdale Bank PLC:企業の戦略的SWOT分析
    Clydesdale Bank PLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Agilent Technologies Inc (A):企業の財務・戦略的SWOT分析
    Agilent Technologies Inc (A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Sir Robert McAlpine Ltd:企業の戦略的SWOT分析
    Sir Robert McAlpine Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Cancer Research Technology Ltd.:企業のM&A・事業提携・投資動向
    Cancer Research Technology Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Cancer Research Technology Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • Eagle Materials Inc (EXP):企業の財務・戦略的SWOT分析
    Eagle Materials Inc (EXP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • The Export-Import Bank of Korea:電力:M&Aディール及び事業提携情報
    Summary The Export-Import Bank of Korea (Korea Eximbank) is a bank that offers financial products and services. The company’s products include loans, guarantees, bonds, trade finance products, investment products, and structured products. Its loan products comprise export related loans, overseas bus …
  • Entreprise Tunisienne d’Activites Petrolieres:企業の戦略的SWOT分析
    Entreprise Tunisienne d'Activites Petrolieres - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors …
  • The Bank of Iwate Ltd:企業の戦略・SWOT・財務情報
    The Bank of Iwate Ltd - Strategy, SWOT and Corporate Finance Report Summary The Bank of Iwate Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • West Hertfordshire Hospitals NHS Trust:企業の戦略的SWOT分析
    West Hertfordshire Hospitals NHS Trust - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • Breckenridge Pharmaceutical Inc-製薬・医療分野:企業M&A・提携分析
    Summary Breckenridge Pharmaceutical Inc (Breckenridge), a subsidiary of Laboratorios Del Dr Esteve SA is a healthcare solution provider that research, develops and markets various generic prescription products. The company provides products including stradiol, oxcarbazepine tablets, methylprednisolo …
  • Laboratory Corporation of America Holdings:企業の戦略・SWOT・財務分析
    Laboratory Corporation of America Holdings - Strategy, SWOT and Corporate Finance Report Summary Laboratory Corporation of America Holdings - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Pivotal Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Pivotal Therapeutics Inc (Pivotal Therapeutics) is a pharmaceutical company that develops and markets Omega-3 based therapies and therapeutic products for cardiovascular disorders. The company offers products such as VASCAZEN, a medical food formulated for the dietary management of an Omega- …
  • Magnit:企業の戦略・SWOT・財務情報
    Magnit - Strategy, SWOT and Corporate Finance Report Summary Magnit - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Malaysian Resources Corporation Berhad (MRCB):企業の財務・戦略的SWOT分析
    Malaysian Resources Corporation Berhad (MRCB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • 3E sanv:企業の戦略的SWOT分析
    3E sanv - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • PT Telekomunikasi Indonesia, Tbk:企業の戦略・SWOT・財務情報
    PT Telekomunikasi Indonesia, Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Telekomunikasi Indonesia, Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆